Biogen Idec (BIIB) says a study of its experimental multiple sclerosis drug showed positive...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen Idec (BIIB) says a study of its experimental multiple sclerosis drug showed positive results, with patients demonstrating a statistically significant reduction in relapsing-remitting MS at two years compared with those patients taking a placebo. (PR)